| |
| |
|
| Insider
Information: |
Rowland Lloyd A |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
119,229 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$32,031 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
119,229 |
|
|
| Total
Value |
$32,031 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
VP, Chief Compliance O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Xencor Inc |
XNCR |
Sr. V.P. and General C... |
2015-12-15 |
1,501 |
2015-12-15 |
0 |
Premium* |
|
|
Cytomx Therapeutics, Inc. |
CTMX |
|
2024-03-19 |
117,728 |
2018-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
Vice President & General |
• – – |
2003-10-28 |
5 |
A |
$0.00 |
$0 |
D/D |
250 |
5,354 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Legal & General Counsel |
• – – |
2006-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
135 |
19,821 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Governance Compliance & Cor |
• – – |
2009-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,550 |
3,455 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Governance Compliance & Co |
• – – |
2010-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,360 |
4,815 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance OfficerVP |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,300 |
36,366 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance OfficerVP |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,630 |
6,445 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance OfficerVP |
• – – |
2012-02-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
32,009 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,767) |
30,903 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,529 |
7,974 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
37,603 |
0 |
- |
|
| XNCR |
Xencor Inc |
Sr. V.P. and General Counsel |
• – – |
2015-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,501 |
1,501 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
34,291 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2022-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
49,291 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
73,132 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
86,095 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
102,073 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
122,996 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Governance Compliance & Cor |
• – – |
2008-08-18 |
4 |
OE |
$16.54 |
$1,654 |
D/D |
100 |
24,527 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Governance Compliance & Cor |
• – – |
2008-08-18 |
4 |
AS |
$35.00 |
$3,500 |
D/D |
(100) |
24,427 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-03-16 |
4 |
S |
$1.98 |
$4,031 |
D/D |
(2,037) |
71,095 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-03 |
4/A |
OE |
$5.59 |
$5,590 |
D/D |
1,000 |
13,600 |
|
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-12-20 |
4 |
S |
$1.38 |
$5,629 |
D/D |
(4,077) |
97,996 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Gov/Compliance, Secretary |
– – – |
2008-02-01 |
4 |
A |
$37.00 |
$6,734 |
D/D |
182 |
23,976 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP Governance Compliance & Cor |
• – – |
2009-02-03 |
4 |
A |
$11.80 |
$6,903 |
D/D |
585 |
25,113 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-09-22 |
4 |
S |
$1.30 |
$7,135 |
D/D |
(5,486) |
80,609 |
0 |
- |
|
103 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
